Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

H. pylori Stool-Antigen Immunoassays to fit your testing requirements

Products are for professional/laboratory use only.

Savyon Diagnostics is now offering two assays for detection of H. pylori active infection. The CoproELISA™ H. pylori test which allows manual or automatic high throughput testing within 75 minutes and the CoproStrip™ H. pylori rapid test which offers simple, one-step testing within 10 minutes.

Both tests are based on the detection of a unique H. pylori antigen from the faeces of symptomatic patients.

Current consensus guidelines* recommend testing H. pylori active infection by stool antigen immunoassays such as the CoproStrip™ and CoproELISA™ H. pylori.

CoproELISA™ H. pylori

  • Accurate (>95% sensitivity & specificity)
  • Flexible (1-96 samples /run)
  • Short & Simple Protocol
  • Manual or Automation Procedures
  • Affordable

CoproStrip™ H. pylori

  • Rapid (10 min)
  • Accurate (>95% sensitivity & specificity)
  • User friendly
  • Only one minute of set-up
  • Affordable

Discover CoproELISA™ H. pylori and CoproStrip™ H. pylori

Download Flyer >

Request a quote

Contact Us Now >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article